GREAT POINT PARTNERS LLC
13F Portfolio Filings
- Most recent 13FQ1 2025
- Locationgreenwich, CT
- CIK0001281446
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
32 | $188.80M | CYTK, KALV, EOLS, ABIVAX SA | 13F-HR | May 15, 2025 | 000117266125002331 | ||
26 | $212.20M | ISI, CYTK, KALV, VRDN | 13F-HR | Feb 14, 2025 | 000117266125001157 | ||
30 | $339.76M | NGNE, ABIVAX SA, PLRX, EOLS | 13F-HR | Nov 13, 2024 | 000117266124004656 | ||
33 | $522.02M | UROGEN PHARMA LTD, NGNE, ABIVAX SA, MERUS N V | 13F-HR | Aug 14, 2024 | 000117266124003577 | ||
35 | $641.64M | NGNE, ALPN, UROGEN PHARMA LTD, ABIVAX SA | 13F-HR | May 15, 2024 | 000117266124002523 | ||
34 | $586.73M | ALPN, CYTK, UROGEN PHARMA LTD, PLRX | 13F-HR | Feb 14, 2024 | 000117266124001436 | ||
42 | $549.04M | UROGEN PHARMA LTD, ALPN, PLRX, PCVX | 13F-HR | Nov 14, 2023 | 000117266123004025 | ||
40 | $510.83M | ALPN, RARE, PCVX, PLRX | 13F-HR | Aug 14, 2023 | 000117266123003165 | ||
44 | $509.32M | PLRX, XENON PHARMACEUTICALS INC, ALPN, RARE | 13F-HR | May 15, 2023 | 000117266123002293 | ||
42 | $510.19M | PCVX, XENON PHARMACEUTICALS INC, RAPT, ALPN | 13F-HR | Feb 14, 2023 | 000117266123001300 | ||
40 | $415.31M | XENON PHARMACEUTICALS INC, JAZZ PHARMACEUTICALS PLC, PNT, ALPN | 13F-HR | Nov 14, 2022 | 000117266122002573 | ||
35 | $416.96M | XENON PHARMACEUTICALS INC, JAZZ PHARMACEUTICALS PLC, CYTK, TRAVERE THERAPEUTICS INC | 13F-HR | Aug 15, 2022 | 000117266122001993 | ||
30 | $413.78M | EX9, XENON PHARMACEUTICALS INC, TRAVERE THERAPEUTICS INC, BCYC | 13F-HR | May 16, 2022 | 000117266122001465 | ||
36 | $450.12M | ARNA, EX9, XENON PHARMACEUTICALS INC, TRAVERE THERAPEUTICS INC | 13F-HR | Feb 14, 2022 | 000117266122000487 | ||
36 | $429.47M | EX9, ARNA, KDMN, BCAB | 13F-HR | Nov 15, 2021 | 000117266121002382 | ||
30 | $476.72M | MGNX, RCKT, ARNA, UTH | 13F-HR | Aug 16, 2021 | 000117266121001868 | ||
28 | $483.86M | MGNX, RCKT, IOVA, SAGE | 13F-HR | May 17, 2021 | 000117266121001313 | ||
33 | $615.67M | GWPH, IOVA, SAGE, ACAD | 13F-HR | Feb 16, 2021 | 000117266121000726 | ||
34 | $1.11B | IOVA, SAGE, ACAD, ARNA | 13F-HR | Nov 16, 2020 | 000117266120002326 | ||
36 | $1.25B | CNST, IOVA, ZYME, ACAD | 13F-HR | Aug 14, 2020 | 000117266120001861 | ||
36 | $957.14M | ACAD, ZYME, PTCT, IOVA | 13F-HR | May 15, 2020 | 000117266120001361 | ||
37 | $1.15B | IOVA, ZYME, PTCT, AXSM | 13F-HR | Feb 14, 2020 | 000117266120000830 | ||
41 | $1.09B | IOVA, ZGNX, ACAD, 2393707D | 13F-HR | Nov 15, 2019 | 000093041319002849 | ||
30 | $900.81B | IOVA, PTCT, ZGNX, 2393707D | 13F-HR | Aug 14, 2019 | 000093041319002313 | ||
40 | $1.01B | PTCT, ZGNX, GBT, 2393707D | 13F-HR | May 14, 2019 | 000093041319001676 | ||
40 | $791.19M | BCRX, IOVA, GBT, ACCELERON PHARMA INC | 13F-HR | Feb 15, 2019 | 000093041319000592 | ||
30 | $641.67M | BCRX, ACCELERON PHARMA INC, ZFGNUSD, IOVA | 13F-HR | Nov 14, 2018 | 000093041318003323 | ||
38 | $721.56M | PTCT, KURA, IOVA, BCRX | 13F-HR | Aug 14, 2018 | 000093041318002592 | ||
37 | $673.40B | IOVA, ARNA, KURA, PTCT | 13F-HR | May 14, 2018 | 000093041318001815 | ||
39 | $586.07M | ZGNX, ARNA, KURA, SAGE | 13F-HR | Feb 14, 2018 | 000093041318000474 | ||
37 | $514.03M | ZGNX, UTH, ARNA, CNCE | 13F-HR | Nov 14, 2017 | 000093041317003778 | ||
38 | $558.19M | ARNA, ADAMAS PHARMACEUTICALS INC, VNDA, ZGNX | 13F-HR | Aug 14, 2017 | 000093041317002918 | ||
37 | $503.51M | ADAMAS PHARMACEUTICALS INC, CNCE, SGYPQ, VNDA | 13F-HR | May 15, 2017 | 000093041317002121 | ||
35 | $486.76M | ADAMAS PHARMACEUTICALS INC, FOAMIX PHARMACEUTICALS LTD, VNDA, SGYPQ | 13F-HR | Feb 14, 2017 | 000093041317000546 | ||
35 | $392.07M | VNDA, ADAMAS PHARMACEUTICALS INC, SGYPQ, ZGNX | 13F-HR | Nov 14, 2016 | 000093041316008703 | ||
39 | $349.23M | ADAMAS PHARMACEUTICALS INC, VNDA, SGYPQ, EX9 | 13F-HR | Aug 15, 2016 | 000093041316007885 | ||
33 | $278.67M | ADAMAS PHARMACEUTICALS INC, FPRX, VNDA, ZGNX | 13F-HR | May 16, 2016 | 000093041316007144 | ||
25 | $238.30M | ADAMAS PHARMACEUTICALS INC, FPRX, ZGNX, VNDA | 13F-HR | Feb 16, 2016 | 000093041316005528 | ||
36 | $252.82M | VNDA, FPRX, CNXR, ADAMAS PHARMACEUTICALS INC | 13F-HR | Nov 16, 2015 | 000093041315004329 | ||
34 | $256.52M | CNXR, ADAMAS PHARMACEUTICALS INC, VNDA, FPRX | 13F-HR | Aug 14, 2015 | 000093041315003355 | ||
33 | $227.22M | CNXR, HPTX, VNDA, ORTHOFIX INTL N V | 13F-HR | May 15, 2015 | 000093041315002517 | ||
28 | $207.76M | CNXR, HPTX, ALIM, OCRX | 13F-HR | Feb 17, 2015 | 000093041315000640 | ||
37 | $232.82M | HPTX, NBIX, INFIQ, ALIM | 13F-HR | Nov 14, 2014 | 000093041314004572 | ||
38 | $224.81M | NBIX, HPTX, DSCI, THORATEC CORP | 13F-HR | Aug 14, 2014 | 000093041314003671 | ||
36 | $191.48M | FURX, HPTX, PAIN THERAPEUTICS INC, ALIM | 13F-HR | May 15, 2014 | 000093041314002534 | ||
28 | $141.60M | HPTX, PAIN THERAPEUTICS INC, FURX, SUNSHINE HEART INC | 13F-HR | Feb 14, 2014 | 000093041314000601 |